US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
Lo Chung-mau: 2026/27 Govt Healthcare Recurrent Spending Budget HKD118.9B, Up 4% YoY
Secretary for Health Lo Chung-mau said at a special meeting of the Legislative Council Finance Committee today (13th) that the governments recurrent expenditure budget on healthca...
Reset
Send
The window will close in 5 seconds
Lo Chung-mau: 2026/27 Govt Healthcare Recurrent Spending Budget HKD118.9B, Up 4% YoY
Recommend
2
Positive
1
Negative
4
 
 

Secretary for Health Lo Chung-mau said at a special meeting of the Legislative Council Finance Committee today (13th) that the governments recurrent expenditure budget on healthcare for 2026/27 is HKD118.9 billion, representing a YoY increase of 4% from the revised estimate for 2025/26 and accounting for 19.8% of total government recurrent expenditure. Of this, recurrent funding allocated to the Hospital Authority for 2026/27 amounts to HKD101.8 billion, up 2.8% from the revised estimate of HKD99.0 billion for 2025/26, to meet growing service demand.

Lo said key new initiatives to be implemented by the Hospital Authority include reform of public healthcare charges to strengthen protection for patients who are "underprivileged, urgent, serious and critical"; enhancing both quantity and quality of services, including the addition of about 200 hospital beds; shortening waiting times for specialist outpatient services; establishing stroke centres and chest pain centres; and continuing development of smart wards, smart clinics and smart pharmacies. Regarding regulation of private healthcare, the government plans to submit subsidiary legislation to the Legislative Council within this year to enhance fee transparency.

He added that the first-phase "primary evaluation" mechanism for new drug registration was implemented in March this year. In 2H26, the government will introduce a bill to establish the Hong Kong Centre for Medical Products Regulation, with a target to set up the centre before year-end, alongside legislative proposals for the regulation of medical devices. In addition, the "International Institute of Clinical Trials" will be established within 2027, while the "Real-World Study and Application Centre" will develop a "Greater Bay Area Real-World Data Platform".

On healthcare manpower, Lo noted that Hong Kong continues to face an overall shortage of healthcare professionals, particularly in the public sector. For example, there are currently more than 3,500 nursing vacancies in public healthcare institutions, representing a vacancy rate of about 10%. Going forward, the government will continue a dual-track approach of local training and appropriate recruitment of non-locally trained healthcare professionals to ensure sufficient manpower. It also supports the Hong Kong University of Science and Technology in establishing a third medical school, with land and resources reserved for developing a new campus and integrated medical teaching and research hospital in Ngau Tam Mei, targeting the admission of the first cohort of 50 students in the 2028/29 academic year.

Lo also said the government will extend the Elderly Health Care Voucher Greater Incentive Pilot Scheme to end-2028, involving additional expenditure of HKD1 billion. In principle, elderly persons who accumulate HKD1,000 or more in voucher spending on designated primary healthcare services within the same year will receive an additional HKD500 health care voucher incentive.

Separately, preliminary data show that Hong Kongs smoking rate declined from 9.1% in 2023 to 8.5% in 2025, a record low. The number of daily smokers has decreased by nearly 100,000 compared with the pre-pandemic level in 2019, reflecting significant effectiveness of tobacco control efforts. The government will continue to implement various tobacco control measures and advance the five-year "eHealth+" plan to build an integrated healthcare information infrastructure covering data interoperability, service delivery and process management, creating a territory-wide digital health network connected to the Greater Bay Area. (hc/da)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Preferred News
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

As a convenience to users, the AASTOCKS.com Limited has added a translation feature developed by Azure OpenAI to assist users in understanding information on this platform in languages other than Chinese. The translated text may lose some of its intended meaning. Some items on the site, including images containing text, videos with captioning, PDF documents, or maps may not be translated, and some features may not work in the translated versions.

The AASTOCKS.com Limited does not guarantee the accuracy of translations, and the translated text should not be considered exact. The text translated is made available on an as is and as available basis without any warranties of any kind. The AASTOCKS.com Limited will not accept any liability for damages or losses of any kind caused by the use of the translation feature.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 9 February 2026.